Company Long-Term Liabilities: Kezar Life Sciences Inc. (KZR)
The price action of Kezar Life Sciences (KZR) securities reflects the impact of zetomipzomib's success in treating renal pathologies and the potential for acquisition by industry behemoths, with the indicator standing at 0.00. Expected refined test results for the lead drug will serve as new catalysts, as previous challenges are already priced in. The business relies on outsourcing production and research, maintaining its status as a mobile scientific team.
Summary analytical data breakdowns for Kezar Life Sciences, Inc (KZR)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Kezar Life Sciences|KZR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Kezar Life Sciences Inc|KZR - Company Debts|Debt to Book Value Kezar Life Sciences|KZR - Company Long-Term Liabilities|Company Short-Term Debts Kezar Life Sciences|Immediate Liquidity Ratio kezarlifesciences.com
- business earnings and investment ratios data:
Analysis of all company metrics:KZR - kezarlifesciences.com
Long-term debt measures the volume of obligations with maturities exceeding one year, determining financial stability and the cost of borrowed capital within the balance sheet structure. By analyzing the trend of the business's long-term borrowed capital, an investor assesses the ability of Kezar Life Sciences (KZR) to fund costly research against lupus nephritis amidst a lack of revenue and a systematic reduction of existing cash reserves.
Competitor analysis for Kezar Life Sciences
Company Long-Term Loans and Borrowings ARGX|BNTX - Company Long-Term Debt|abivax.com (ABVX) - Company Long-Term Liabilities|ADMA: Company Long-Term Debts|Protagonist Corp (PTGX) - Company Long-Term Debts|Company Long-Term Liabilities IMVT|KNSA: Company Long-Term Loans and Borrowings|Company Long-Term Debts GRFS|Long-Term Debt Volume Adaptive Biotech|Company Long-Term Debt Celldex CLDX|AUPH - Company Long-Term Liabilities|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Long-Term Liabilities|Pharvaris NV (PHVS) - Company Long-Term Debts|Company Long-Term Debt AbCellera Biologics|Company Long-Term Indebtedness TRML (Tourmaline)|Company Long-Term Debts PGEN|PHAR - Long-Term Debt|Company Long-Term Debt Nektar Therapeutics Inc. NKTR|Company Long-Term Debts Upstream Bio, Inc. UPB|Zenas Biopharma, Inc. - Company Long-Term Debts|Long-Term Debt Immunome Bio|GOSS (Gossamer Bio, Inc.) - Company Long-Term Liabilities|Long-Term Liabilities KALV (kalvista.com)|SEPN (Septerna) - Company Long-Term Debts|Company Long-Term Debts Pieris Pharma|Company Long-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Long-Term Loans and Borrowings|AnaptysBio, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ATXS|ENGN - Company Long-Term Debt|RAPT: Company Long-Term Debt|JBIO: Company Long-Term Debts|ACRS - Long-Term Debt Volume|KYTX (Kyverna Therapeutics) - Company Long-Term Debts|tizianalifesciences.com - Long-Term Liabilities|Company Long-Term Debts CABA|VTYX - Long-Term Debt|Theratechnologies Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AVTX|ELDN - Company Long-Term Debt|Long-Term Debt Volume agenusbio.com AGEN|CLYM: Company Long-Term Debts|Company Long-Term Liabilities zurabio.com|ATYR (aTyr) - Company Long-Term Debts|Adagene Corp (ADAG) - Long-Term Debt Volume|Company Long-Term Debts IMA|STTK - Long-Term Debt|Company Long-Term Debt Equillium EQ|CNTB: Company Long-Term Indebtedness|Immunic Inc - Company Long-Term Debts|Atara Biotherapeutics (ATRA) - Company Long-Term Liabilities|IFRX: Company Long-Term Debts|Long-Term Debt x4pharma.com (XFOR)|Company Long-Term Debt Adicet Bio Inc.|Celularity Corp (CELU) - Long-Term Debt Volume|Company Long-Term Debt INmune Bio Corp (INMB)|Company Long-Term Debts Barinthus Biotherapeutics Corp (BRNS)|SAB Biotherapeutics - Company Long-Term Liabilities|AKTX (akaritx.com) - Long-Term Liabilities|ENLV - Company Long-Term Debt|Company Long-Term Loans and Borrowings QTTB (Q32 Bio Inc.)|GeoVax Labs Inc (GOVX) - Company Long-Term Debt|Long-Term Liabilities EDSA (Edesa Biotech Corp)|IBIO (iBio, Inc.) - Company Long-Term Debts|CARM: Company Long-Term Loans and Borrowings|Company Long-Term Debts XTLB|Company Long-Term Debts boltbio.com (BOLT)|Company Long-Term Debt HCW Biologics HCWB|Company Long-Term Loans and Borrowings APVO|AIM - Company Long-Term Debt|Aditxt (ADTX) - Company Long-Term Liabilities|GRI: Company Long-Term Debts|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Liabilities HIND|REVB: Company Long-Term Loans and Borrowings|Company Long-Term Debts INDP|Long-Term Debt Volume scinai.com|Company Long-Term Debt CalciMedica CALI|AFMD - Company Long-Term Liabilities|ALLK - Company Long-Term Debt|HOOKIPA Pharma Inc. (HOOK) - Company Long-Term Liabilities|IGMS (igmbio.com) - Company Long-Term Liabilities|iteostherapeutics.com (ITOS) - Company Long-Term Debts|Company Long-Term Debt Ocean Biomedical|Company Long-Term Indebtedness TCBP (TC BioPharm (Holdings) Plc)|Company Long-Term Debts THRD